A pilot study of the use of low dose human menopausal gonadotropin in ovulation induction

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 109, Issue 1, 2003, Pages 55-59

  Ku, Seung Yup ^a   Suh, Chang Suk ^a,b   Kim, Seok Hyun ^a,b   Choi, Young Min ^a,b   Kim, Jung Gu ^a   Moon, Shin Yong ^a,b  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

Controlled ovarian hyperstimulation; FSH; GnRH agonist; hMG; Ultralong protocol

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; GONADORELIN AGONIST; HUMAN MENOPAUSAL GONADOTROPIN; PROGESTERONE; TRIPTORELIN; UROFOLLITROPIN;

ADENOMYOSIS; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG PURIFICATION; DRUG USE; EMBRYO; EMBRYO TRANSFER; ENDOMETRIOSIS; ESTRADIOL BLOOD LEVEL; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HUMAN; LOW DRUG DOSE; MENOPAUSE; OVARY HYPERSTIMULATION; OVULATION INDUCTION; PERITONEUM; PILOT STUDY; PREGNANCY RATE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; UTERUS; UTERUS MYOMA;

EID: 0038343318     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-2115(02)00476-1     Document Type: Article

References (30)

1. Filicori M., Cognigni G.E., Taraborrelli S., Spettoli D., Ciampaglia W., de Fatis C.T. Low-dose human chorionic gonadotropin therapy can improve sensitivity to exogenous follicle-stimulating hormone in patients with secondary amenorrhea. Fertil. Steril. 72:1999;1118-1120.
2. Filicori M., Cognigni G.E., Taraborrelli S., Spettoli D., Ciampaglia W., de Fatis C.T.et al. Luteinizing hormone activity supplementation enhances follicle-stimulating hormone efficacy and improves ovulation induction outcome. J. Clin. Endocrinol. Metab. 84:1999;2659-2663.
3. Filicori M. The role of luteinizing hormone in folliculogenesis and ovulation induction. Fertil. Steril. 71:1999;405-414.
4. Phelps J.Y., Figueira-Armada L., Levine A.S., Vlahos N.P., Roshanfekr D., Zacur H.A.et al. Exogenous luteinizing hormone (LH) increases estradiol response patterns in poor responders with low serum LH concentrations. J. Assist. Reprod. Genet. 16:1999;363-368.
5. Stouffer RL, Dahl KD, Hibbert ML, Weston AM, Wolf DP, Zelinski-Wooten MB. Relative roles of gonadotropins and intraovarian steroids on the outcome of ovulation induction. In: Filicori M, Flamigni C, editors. Ovulation induction: update 98. NY: The Parthenon Publishing Group; 1998. p. 1-10.
6. Wingfield M., Healy D.L. Endometriosis: medical therapy. Baillieres Clin. Obstet. Gynaecol. 7:1993;813-838.
7. Bergqvist I.A. Hormonal regulation of endometriosis and the rationales and effects of gonadotrophin-releasing hormone agonist treatment: a review. Hum. Reprod. 10:1995;446-452.
8. Kettel L.M., Hummel W.P. Modern medical management of endometriosis. Obstet. Gynecol. Clin. North Am. 24:1997;361-373.
9. Hirata J.D., Moghissi K.S., Ginsburg K.A. Pregnancy after medical therapy of adenomyosis with a gonadotropin-releasing hormone agonist. Fertil. Steril. 59:1993;444-445.
10. Nelson J.R., Corson S.L. Long-term management of adenomyosis with a gonadotropin-releasing hormone agonist: a case report. Fertil. Steril. 59:1993;441-443.
11. Silva P.D., Perkins H.E., Schauberger C.W. Live birth after treatment of severe adenomyosis with a gonadotropin-releasing hormone agonist. Fertil. Steril. 61:1994;171-172.
12. Ozaki T., Takahashi K., Okada M., Kurioka H., Miyazaki K. Live birth after conservative surgery for severe adenomyosis following magnetic resonance imaging and gonadotropin-releasing hormone agonist therapy. Int. J. Fertil. Womens Med. 44:1999;260-264.
13. Mencaglia L., Tantini C. GnRH agonist analogs and hysteroscopic resection of myomas. Int. J. Gynaecol. Obstet. 43:1993;285-288.
14. Palagiano A., Trotta C., Izzo A., Ragucci N. Use of triptorelin in the medical treatment of uterine myoma. Minerva Ginecol. 45:1993;171-175.
15. Vercellini P., Bocciolone L., Colombo A., Vendola N., Meschia M., Bolis G. Gonadotropin releasing hormone agonist treatment before hysterectomy for menorrhagia and uterine leiomyomas. Acta Obstet. Gynecol. Scand. 72:1993;369-373.
16. Sims J.A., Brzyski R., Hansen K., Coddington C.C. 3rd Use of a gonadotropin releasing hormone agonist before vaginal surgery for cervical leiomyomas. A report of two cases. J. Reprod. Med. 39:1994;660-662.
17. Broekmans F.J. GnRH agonists and uterine leiomyomas. Hum. Reprod. 11(3):1996;3-25.
18. Kim C.H., Cho Y.K., Mok J.E. Simplified ultralong protocol of gonadotrophin-releasing hormone agonist for ovulation induction with intrauterine insemination in patients with endometriosis. Hum. Reprod. 11:1996;398-402.
19. Fleming R., Lloyd F., Herbert M., Fenwick J., Griffiths T., Murdoch A. Effects of profound suppression of luteinizing hormone during ovarian stimulation on follicular activity. Hum. Reprod. 13:1998;1788-1792.
20. The American Society for Reproductive Medicine. Revised American Society for Reproductive Medicine Classification of Endometriosis: 1996. Fertil Steril 1997;67:817-21.
21. Moon S.Y., Kim S.H., Jee B.C., Jung B.J., Suh C.S., Lee J.Y. The outcome of sperm retrieval and intracytoplasmic sperm injection in patients with obstructive azoospermia: impact of previous tuberculous epididymitis. J. Assist. Reprod. Genet. 16:1999;431-435.
22. Moon S.Y., Kim S.H., Jung B.J., Jee B.C., Suh C.S., Lee J.Y. Influence of female age on pregnancy outcome in in vitro fertilization and embryo transfer patients undergoing intracytoplasmic sperm injection. J. Obstet. Gynaecol. Res. 26:2000;49-54.
23. Couzinet B., Lestrat N., Brailly S., Forest M., Schaison G. Stimulation of ovarian follicular maturation with pure follicle-stimulating hormone in women with gonadotropin deficiency. J. Clin. Endocrinol. Metab. 66:1988;552-556.
24. The European Recombinant Human LH Study Group. Recombinant human luteinizing hormone (LH) to support recombinant human follicle-stimulating hormone (FSH)-induced follicular development in LH- and FSH-deficient anovulatory women: a dose-finding study. J Clin Endocrinol Metab 1998;83:1507-14.
25. Martikainen H., Ronnberg L., Puistola U., Kirkinen P., Ruokonen A., Nikula H.et al. Comparison of the effects of follicle-stimulating hormone and human menopausal gonadotropin on peripheral serum and follicular fluid hormones during ovarian stimulation. Fertil. Steril. 46:1986;317-320.
26. Fried G., Harlin J., Csemiczky G., Wramsby H. Controlled ovarian stimulation using highly purified FSH results in a lower serum oestradiol profile in the follicular phase as compared with HMG. Hum. Reprod. 11:1996;474-477.
27. Soderstrom-Anttila V., Foudila T., Hovatta O. A randomized comparative study of highly purified follicle stimulating hormone and human menopausal gonadotrophin for ovarian hyperstimulation in an oocyte donation programme. Hum. Reprod. 11:1996;1864-1870.
28. Westergaard L.G., Erb K., Laursen S., Rasmussen P.E., Rex S. The effect of human menopausal gonadotrophin and highly purified, urine-derived follicle stimulating hormone on the outcome of in-vitro fertilization in down-regulated normogonadotrophic women. Hum. Reprod. 11:1996;1209-1213.
29. Gordon U.D., Harrison R.F., Fawzy M., Hennelly B., Gordon A.C. A randomized prospective assessor-blind evaluation of luteinizing hormone dosage and in vitro fertilization outcome. Fertil. Steril. 75:2001;324-331.
30. Borm G., Mannaerts B. Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial. Hum. Reprod. 15:2000;1490-1498.